“ we founded Editas Medicine with $43 million in financing from three venture capital firms. ”
in 2011, Rachel and I founded a company called Caribou Biosciences to commercialize the Cas proteins.
~ Jennifer A. Doudna
Editas Medicine has an exclusive multimillion-dollar license with Juno Therapeutics to develop T cell therapies
PGD has also been used for other controversial purposes, such as the birth if so-called savior siblings, destined from the moment of implantation not only to live their own lives, but also to serve as organ or cell donors for a sibling.
As we began discussing authorship of a white paper summarizing our conclusions, we debated who our target audience should be and what kind of outcome we were hoping to achieve.
